EndoCross · raw details

Medical Devices for Cardiovascular Treatment · Yokne'am Illit · Founded 2006

inactive Mature ← back to profile

Highlights

1 patent

About

Medical Devices for Cardiovascular Treatment

EndoCross develops and markets solutions to treat challenging lesions, including chronic total occlusions (CTOs). Its first product, the ENABLER-P Catheter System, is CE marked and designed for use in the peripheral vasculature, including above-the-knee and below-the-knee vessels. The company is also introducing the ENABLER-C Catheter System for use in coronary environments. The ENABLER technology can advance a guidewire in challenging environments, including crossing long and severely calcified CTOs. Using traditional balloon technologies, EndoCross has developed a balloon designed to provide guidewire support, centralization, and controlled advancement. The full ENABLER Catheter System comprises the ENABLER-P Catheter, the ENABLER Pressure Control Unit, a syringe set, and a sterile cover.

Identity

NameEndoCross
Slugendocross
Type / kindstartup
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7q_a4IDA

Status

Statusinactive
Status reasonNon Active, Oct 2017
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtNorth District
HQ cityYokne'am Illit
HQ addressYokne'am Illit, Israel

Web & social

LinkedInhttps://www.linkedin.com/company/1171248

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
cathetersmedical-deviceshospitalscardiovascularsurgeryvascularcardiology

Funding

Total raised$2.5M
Current stageMature

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}